Clinical Trial Update: Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated metabolic cofactor supplementation in patients with Alzheimer's disease and Parkinson's disease; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease

Snippet

Sponsor: Istanbul Medipol University Hospital | Conditions: Alzheimer Disease, Parkinson Disease | Phase 2 | Status: COMPLETED